JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Pulmonary aspergillosis after COVID-19, a case report
Abstract
COVID-19 is an infectious disease that spreads worldwide, can progress rapidly, affect individuals of all ages, and cause death, especially in the elderly and people with chronic diseases. It has predisposed a relatively high number of patients to acute respiratory distress syndrome, and co-infections are a frequent complication, especially during prolonged hospital stays. Bacterial or viral co-infections with SARS-CoV-2 have been reported in many studies, but knowledge of Aspergillus co-infection in patients with COVID-19 is limited. This study presents a 57-year-old male patient with COVID-19 who had had no lung disease before COVID-19 pneumonia. However, after COVID-19 pneumonia with sequels and treatments that include corticosteroids and IL-6 receptor antagonists, an invasive pulmonary aspergillus (IPA) cavity occurred immediately. In addition to the fact that COVID-19 infection progresses with destructive parenchymal damage and sequelae, the effectiveness of treatment is limited, and treatment-related side effects and complications can be examined. Therefore, clinical and radiological follow-up of patients whose symptoms persist after infection is essential.

Keywords : Aspergillosis, COVID-19, lobectomy, postcovid pulmonary aspergillosis

Download Article


1. Talento AF, Hoenigl M. Fungal infections complicating COVID-19:with the rain comes the spores.J Fungi.2020;6(4):279. doi:10.3390/jof6040279
2. Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunisticinfections: a snapshot on the current reports.Clin Experim Med.2022;22(3):327-346.
3. Mulet Bayona JV, Tormo Palop N, Salvador García C, et al. Impact ofthe SARS-CoV-2 pandemic in candidaemia, invasive aspergillosis andantifungal consumption in a tertiary hospital.J Fungi.2021;7(6):440.
4. Bassetti M, Giacobbe DR, Grecchi C, Rebuffi C, Zuccaro V, ScudellerL. Performance of existing definitions and tests for the diagnosis ofinvasive aspergillosis in critically ill, adult patients: a systematic reviewwith qualitative evidence synthesis.J Infect.2020;81(1):131-141.
5. Marr KA, Platt A, Tornheim JA, Zhang SX, Datta K, Cardozo C.Aspergillosis complicating severe coronavirus disease.Emerg InfectDis.2021;27(1):18.
6. Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasivepulmonary aspergillosis among intubated patients with COVID-19: aprospective study.Clin Infect Dis.2021;73(11):e3606-e3614.
Article available in :
Volume 2, Issue 2, 2024
Page : 42-44
https://doi.org/10.51271/JOPIC-0034
Article Information
Received : 18 Nis 2024
Accepted : 04 May 2024
Published : 23 May 2024
Corresponding Author :

Gülşen Göktepe: Department of Thoracic Surgery, Kilis Prof. Dr. Alaeddin Yavaşca State Hospital, Kilis, Turkiye

[email protected]
Citation : Göktepe G, Hazer S, Acar LN, Gülhan SŞE. Pulmonary aspergillosis after COVID-19: a case report. J Pulmonol Intens Care. 2024;2(2):42-44.

Read: 539
Download : 601
Cited: 0
_Footer